April 1, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Single-dose 8 mL vial in Kit, Rx onl
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
April 1, 2026DrugsFDA
Teva Pharmaceuticals USA, Inc recalls Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Single-dose 8 mL vial in Kit, Rx onl
Hazard: Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
April 1, 2026DrugsFDA
MACLEODS PHARMA USA, INC recalls Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc., Pri
Hazard: Subpotent Drug
April 1, 2026DrugsFDA
Chiesi USA, Inc. recalls CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 275
Hazard: Lack of Assurance of Sterility
April 1, 2026DrugsFDA
Radnostix recalls Gelatin Capsule Pack for use with the Sodium Iodide I-131 Kit (containing 5 empty capsules and 5 Dibasic Sodium Phosphat
Hazard: Failed Tablet/Capsule Specifications
March 25, 2026DrugsFDA
Cardinal Health 200, LLC recalls Webcol Alcohol Prep pad (70% isopropyl alcohol) 2 ply, 200 count boxes, Cardinal Health 200 LLC 3651 Birchwood Drive, Wa
Hazard: Non-Sterility: microbial contamination identified as Paenibacillus phoenicis
March 25, 2026DrugsFDA
Apotex Corp. recalls Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured f
Hazard: Lack of Assurance of Sterility
March 25, 2026DrugsFDA
SOMERSET THERAPEUTICS LLC recalls Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufac
Hazard: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
March 25, 2026DrugsFDA
Annora Pharma Private Limited recalls Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141
Hazard: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg
March 25, 2026DrugsFDA
STRIDES PHARMA INC recalls Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceutica
Hazard: Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
March 18, 2026DrugsFDA
Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India
Hazard: Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
March 11, 2026DrugsFDA
MYLAN PHARMACEUTICALS INC recalls Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: My
Hazard: Failed Dissolution Specifications
March 11, 2026DrugsFDA
StuffbyNainax recalls MR. 7 SUPER 700000 capsules, 1 capsule blister card, Distributed by mR. 7
Hazard: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared sildenafil and tadalafil
March 11, 2026DrugsFDA
Mohamed Hagar recalls Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945
Hazard: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
March 11, 2026DrugsFDA
New Life Pharma LLC recalls Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, N
Hazard: Lack of Assurance of Sterility
March 11, 2026DrugsFDA
New Life Pharma LLC recalls Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 8
Hazard: Lack of Assurance of Sterility
March 11, 2026DrugsFDA
New Life Pharma LLC recalls Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061,
Hazard: Lack of Assurance of Sterility
March 11, 2026DrugsFDA
New Life Pharma LLC recalls Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, N
Hazard: Lack of Assurance of Sterility
March 11, 2026DrugsFDA
Radnostix recalls Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 4932
Hazard: Presence of Particulate Matter: Due to production issues
March 11, 2026DrugsFDA
ANTHONY TRINH, 123Herbals LLC recalls SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Hazard: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
March 11, 2026DrugsFDA
HTO Nevada Inc. dba Kirkman recalls MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source,
Hazard: Stability Data Does Not Support Expiry Date.
March 11, 2026DrugsFDA
HTO Nevada Inc. dba Kirkman recalls MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.
Hazard: Stability Data Does Not Support Expiry Date.
March 11, 2026DrugsFDA
HTO Nevada Inc. dba Kirkman recalls FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Po
Hazard: Stability Data Does Not Support Expiry Date.
March 11, 2026DrugsFDA
Rising Pharma Holding, Inc. recalls Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceutic
Hazard: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
March 11, 2026DrugsFDA
The Harvard Drug Group LLC recalls Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Maj
Hazard: Defective container; inadequately sealed blister packaging.
March 11, 2026DrugsFDA
Cipla USA, Inc. recalls Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence
Hazard: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
March 11, 2026DrugsFDA
Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Ma
Hazard: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
March 11, 2026DrugsFDA
Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 843
Hazard: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
March 11, 2026DrugsFDA
Harbin Jixianglong Biotech Co., Ltd. recalls Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 8438
Hazard: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
March 11, 2026DrugsFDA
ACME UNITED CORPORATION recalls Antimicrobial Alcohol Hand Wipe, Isopropyl Alcohol 70%, Manufactured for : Custom Packaging Co., Inc, Louisville, KY 402
Hazard: CGMP Deviations